Hematoporphyrin dihydrochloride is used as a photosensitizer in photodynamic therapy; it serves as a substrate for heme-binding protein affinity chromatography; it can be incorporated into resin compositions (e.g., polyalkylene furandicarboxylate resins such as polybutylene furandicarboxylate) to enhance crystallization rates; it induces apoptosis in U87 glioma cells upon red light exposure via ROS generation and mitochondrial membrane potential reduction; it inhibits glioma cell viability in a dose-dependent manner under red light irradiation; and it significantly reduces tumor growth in vivo through direct phototoxic effects on tumor cells and secondary vascular damage, leading to massive coagulative necrosis of tumors.